Kronox Lab Sciences Limited (NSE:KRONOX)

Market Cap	6.53B
Revenue (ttm)	1.00B
Net Income (ttm)	254.67M
Shares Out	37.10M
EPS (ttm)	6.86
PE Ratio	25.66
Forward PE	n/a
Dividend	0.50 (0.28%)
Ex-Dividend Date	Aug 8, 2025

Volume	4,127
Average Volume	23,265
Open	179.05
Previous Close	185.90
Day's Range	179.05 - 184.55
52-Week Range	130.05 - 228.55
Beta	n/a
RSI	45.56
Earnings Date	Jul 31, 2025

About Chimerix

Kronox Lab Sciences Limited manufactures and sells fine chemicals, inorganic chemicals, phosphates, and metallic chemicals in India and internationally. The company provides bulk reagents, such as ACS reagents, and LR, AR and GR reagents; bulk ingredients that includes oral care, pharmacopoeia, food and nutraceutical, personal care and cosmetics, and veterinary pharma and animal health; and specialty chemicals, including tartrates, citrates, hypophosphites, phosphates, hydroxides, EDTA and derivatives, ultra high purity chemicals, custom specif...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 2008
• Employees: 54
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: KRONOX

Financial Performance

In 2024, Kronox Lab Sciences's revenue was 1.00 billion, an increase of 11.50% compared to the previous year's 898.62 million. Earnings were 254.67 million, an increase of 19.28%.